Due to their many adverse effects, oral anticancer agents (OAAs) result in high discontinuation rates and low adherence. While evidence exists that mitigating these adverse effects improves adherence, there is a lack of data demonstrating the impact health system specialty pharmacy (HSSP) pharmacists have on improving discontinuation rates.
Compare discontinuation rates in patients on oral anticancer medication before and after a pharmacist-led check-in protocol is put in place to contact patients within 14 days from therapy start.
Read the Outcomes Study by submitting the form below.